Get the Stockscreener App
35.28
0.62%
0.31
Bright Minds Biosciences Inc stock is traded at $35.28, with a volume of 33,910.
It is up +0.62% in the last 24 hours and up +31.03% over the past month.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
See More
Previous Close:
$35.59
Open:
$35.98
24h Volume:
33,910
Relative Volume:
0.85
Market Cap:
$247.07M
Revenue:
-
Net Income/Loss:
$-4.98M
P/E Ratio:
-26.77
EPS:
-1.3177
Net Cash Flow:
$-3.85M
1W Performance:
+6.04%
1M Performance:
+31.03%
6M Performance:
-18.54%
1Y Performance:
+3,216%
1-Day Range:
$34.45
$35.98
1-Week Range:
$31.98
$36.72
52-Week Range:
$0.94
$79.02
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Name
Bright Minds Biosciences Inc
Sector
Industry
Phone
-
Address
-
Compare DRUG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
35.08 | 250.82M | 0 | -4.98M | -3.85M | -1.3177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
382.26 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.69 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.49 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
670.61 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
295.02 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-13-25 | Initiated | TD Cowen | Buy |
| May-07-25 | Initiated | Chardan Capital Markets | Buy |
| Jan-23-25 | Initiated | Piper Sandler | Overweight |
| Jan-10-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-10-25 | Initiated | H.C. Wainwright | Buy |
| Nov-26-24 | Initiated | Robert W. Baird | Outperform |
View All
Bright Minds Biosciences Inc Stock (DRUG) Latest News
Bright Minds Biosciences Inc. stock outlook for YEARMomentum Screener with Buy and Sell Areas - Newser
How to track smart money flows in Bright Minds Biosciences Inc.Weekly Outlook for Short Term Investors - Newser
Bright Minds Biosciences Inc. Earnings Report Breakdown: What Investors Should KnowReal-Time Investment Signal Forecast with AI - Newser
Chart based exit strategy for Bright Minds Biosciences Inc.Market Correction Proof Stock Screening Analysis - Newser
How Bright Minds Biosciences Inc. stock performs during market volatilityMomentum Prediction Based on AI Backtesting - Newser
Is LIMNW showing signs of accumulationAI Risk Optimized Trade Forecast Planner - Newser
Bright Minds Biosciences Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Consistent Profit Pattern Recognition Tools - Newser
Sentiment analysis tools applied to Bright Minds Biosciences Inc.Free Safe Entry Stock Watch Suggestions - Newser
Will Bright Minds Biosciences Inc. Recover After Recent DeclineInvestment Playbook for Growing Markets Shared - metal.it
Earnings visualization tools for Bright Minds Biosciences Inc.Trading Volume Spike and Reversal Analysis - Newser
What makes Bright Minds Biosciences Inc. stock price move sharplyLong-Term Stock Growth Forecast Insights - Newser
Should I hold or sell Bright Minds Biosciences Inc. stock in 2025Unlock daily market insights for better trades - Jammu Links News
What are the technical indicators suggesting about Bright Minds Biosciences Inc.Invest smarter with data-backed trading alerts - Jammu Links News
What institutional investors are buying Bright Minds Biosciences Inc. stockAchieve rapid financial growth with expert picks - Jammu Links News
What analysts say about Bright Minds Biosciences Inc. stockInvest confidently with actionable market data - Jammu Links News
How many analysts rate Bright Minds Biosciences Inc. as a “Buy”Free Stock Chart Pattern Guide - Jammu Links News
When is Bright Minds Biosciences Inc. stock expected to show significant growthHigh-octane investment opportunities await - Jammu Links News
How strong is Bright Minds Biosciences Inc. company’s balance sheetAchieve exceptional returns with expert guidance - Jammu Links News
What catalysts could drive Bright Minds Biosciences Inc. stock higher in 2025Discover market opportunities others miss - Jammu Links News
Why Bright Minds Biosciences Inc. stock attracts strong analyst attentionVolume Based Entry Signal Summary - beatles.ru
Can Bright Minds Biosciences Inc. stock recover from recent declineFree Low Risk Buy Zone Opportunity Watch - Newser
Why is Bright Minds Biosciences Inc. stock attracting strong analyst attentionRealize consistent double-digit growth - Jammu Links News
What are analysts’ price targets for Bright Minds Biosciences Inc. in the next 12 monthsFind the best stocks for sustainable growth - Jammu Links News
Technical signs of recovery in Bright Minds Biosciences Inc.Free Investment Plan With Growth Optimization - Newser
What are Bright Minds Biosciences Inc. company’s key revenue driversReal Time Alerts For Fast Growth - Jammu Links News
Full technical analysis of Bright Minds Biosciences Inc. stockShort Term Momentum Based Trading Strategy - Newser
What is Bright Minds Biosciences Inc. company’s growth strategyExpert Picks Insights For Fast Growth - jammulinksnews.com
New Product Launches: Will They Boost Bright Minds Biosciences Inc. Stock in 2025Controlled Entry Strategy With Safety Analytics - Newser
Published on: 2025-07-30 02:55:13 - metal.it
Short Interest Drops in Bright Minds Biosciences Inc. After RallyROI Driven Equity Selection With Safety Emphasized - beatles.ru
Bright Minds Biosciences Inc. Sees Relief Buying After Extended DropPattern Alert With ROI Driven Strategy Shared - metal.it
Published on: 2025-07-29 04:17:58 - Newser
Does Bright Minds Biosciences Inc. stock pay reliable dividendsFree Short Term Buy List With Stop Protection - Newser
What are the latest earnings results for Bright Minds Biosciences Inc.Invest in stocks with long-term growth potential - jammulinksnews.com
What is the risk reward ratio of investing in Bright Minds Biosciences Inc. stockDiscover high-growth stocks for your portfolio - jammulinksnews.com
Bright Minds Biosciences Inc Stock (DRUG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bright Minds Biosciences Inc Stock (DRUG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 10% Owner |
Oct 15 '24 |
Buy |
5.53 |
372,591 |
2,061,574 |
825,000 |
| Cormorant Asset Management, LP | 10% Owner |
Oct 16 '24 |
Buy |
23.46 |
50,000 |
1,172,813 |
875,000 |
0.54%
1.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):